On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Miltenyi Biotec BV & Co KG's own share of each project, not the project's full budget.
- Horizon Europe€6.2M · 14 projects
- Horizon 2020€3.9M · 15 projects
Projects
29 EU-funded projects, newest first. Miltenyi Biotec BV & Co KG led 2 of them as coordinator. Each links to the official record.
- iN-KEYPartner
iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY
Horizon Europe · 2026–2031 · Project on CORDIS ↗
€1.1Mtheir share - RAMP-UPAssociated partner
Regenerative Medicine and Advanced Medicinal Therapeutic Products United for PhD excellence
Horizon Europe · 2026–2031 · Project on CORDIS ↗
- S.O.L.A.R.I.S.Coordinator
A NEW DAWN IN NEXT-GENERATION CAR-T MANUFACTURING
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€2.1Mtheir share - LifeLUNGPartner
Improving Life expectancy of LUNG transplant recipients through innovative ex vivo perfusion gene therapy
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€290ktheir share - spaXioAssociated partner
Spatial Crosstalk in Immuno-Oncology
Horizon Europe · 2025–2030 · Project on CORDIS ↗
- T-RAFICPartner
Training network for tracking and controlling therapeutic immune cells in cancer
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€261ktheir share - NANO4TALENTAssociated partner
Post-doctoral talent attraction programme to boost research career in the field of nanomaterials for biomedicine
Horizon Europe · 2025–2029 · Project on CORDIS ↗
- ERDERAAssociated partner
EUROPEAN RARE DISEASES RESEARCH ALLIANCE
Horizon Europe · 2024–2031 · Project on CORDIS ↗
- ARTiDePartner
Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€1.5Mtheir share - FANTOMAssociated partner
Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance
Horizon Europe · 2023–2026 · Project on CORDIS ↗
- CarrerasLeadersAssociated partner
Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
Horizon Europe · 2023–2028 · Project on CORDIS ↗
- T-FITNESSPartner
FINE-TUNING T CELL NETWORKS OF EXHAUSTION BY SYNTHETIC SENSORS
Horizon Europe · 2022–2027 · Project on CORDIS ↗
€754ktheir share - €261ktheir share
- GLIORESOLVEAssociated partner
Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment
Horizon Europe · 2022–2026 · Project on CORDIS ↗
- FAIR CHARMPartner
Fast Infrared Coherent Harmonic Microscopy
Horizon 2020 · 2022–2026 · Project on CORDIS ↗
€792ktheir share - T-OPPartner
Training Network for Optimizing Adoptive T cell Therapy of Cancer
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€253ktheir share - REAPPartner
Revealing drug tolerant persister cells in cancer using contrast enhanced optical coherence and photoacoustic tomography
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€657ktheir share - T2EVOLVEPartner
Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€278ktheir share - INsTRuCTPartner
INnovative Training in Myeloid Regulatory Cell Therapy
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€277ktheir share - €243ktheir share
- NSC-ReconstructPartner
Novel Strategies for Cell-based Neural Reconstruction
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€323ktheir share - ZENITHPartner
ZEbrafish Neuroscience Interdisciplinary Training Hub
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
- RESTOREPartner
RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients
Horizon 2020 · 2019–2020 · Project on CORDIS ↗
€6ktheir share - ENDONANOPartner
Quantitative detection of bacterial endotoxin by novel nanotechnological approaches
Horizon 2020 · 2019–2023 · Project on CORDIS ↗
€288ktheir share - EUROoCPartner
Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€225ktheir share - MATURE-NKPartner
MAnufacturing of TUmour-REactive Natural Killer cells
Horizon 2020 · 2018–2022 · Project on CORDIS ↗
€187ktheir share - TRACEPartner
Transfer of multivirus-specific T-cells following transplantation
Horizon 2020 · 2018–2024 · Project on CORDIS ↗
€130ktheir share - CARATCoordinator
Chimeric Antigen Receptors (CARs) for Advanced Therapies
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€172ktheir share - PIX4LIFEPartner
Silicon Nitride Photonic Integrated Circuit Pilot line for Life Science Applications in the Visible Range
Horizon 2020 · 2016–2020 · Project on CORDIS ↗
€88ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 9 shared projects
- Charite - Universitaetsmedizin BerlinGermany · 8 shared projects
- Miltenyi Biotec GmbHGermany · 8 shared projects
- Technische Universitaet MuenchenGermany · 5 shared projects
- University College LondonUnited Kingdom · 5 shared projects
- Medizinische Universitaet WienAustria · 5 shared projects
- Bundesinstitut Fur Impfstoffe und Biomedizinische ArzneimittelGermany · 5 shared projects
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 4 shared projects
- Katholieke Universiteit LeuvenBelgium · 4 shared projects
- Ludwig-Maximilians-Universitaet MuenchenGermany · 4 shared projects
- Eberhard Karls Universitaet TuebingenGermany · 4 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 4 shared projects
- Stichting Amsterdam UmcNetherlands · 4 shared projects
- University of Newcastle Upon TyneUnited Kingdom · 4 shared projects
- Universitat BaselSwitzerland · 4 shared projects
- Region HovedstadenDenmark · 4 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- biosensing
- business and management
- cells technologies
- computational science
- diabetes
- drug discovery
- ecosystems
- gene therapy
- immunology
- immunotherapy
- innovation management
- laser physics
- manufacturing engineering
- metalloids
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
